Suppr超能文献

大囊性脑转移瘤抽吸后分次伽玛刀放射外科治疗:病例系列及文献复习。

Fractionated Gamma Knife radiosurgery after cyst aspiration for large cystic brain metastases: case series and literature review.

机构信息

Gamma Knife Center, NTT Medical Center Tokyo, Shinagawa-ku, Tokyo, Japan.

Department of Neurosurgery, NTT Medical Center Tokyo, Shinagawa-ku, Tokyo, Japan.

出版信息

Neurosurg Rev. 2022 Oct;45(5):3457-3465. doi: 10.1007/s10143-022-01835-y. Epub 2022 Jul 14.

Abstract

Tumor cyst aspiration followed by Gamma Knife radiosurgery (GKRS) for large cystic brain metastases is a reasonable and effective management strategy. However, even with aspiration, the target lesion tends to exceed the dimensions of an ideal target for stereotactic radiosurgery. In this case, the local tumor control rate and the risk of complication might be a critical challenge. This study is aimed to investigate whether fractionated GKRS (f-GKRS) could solve these problems. Between May 2018 and April 2021, eight consecutive patients with nine lesions were treated with f-GKRS in five or ten sessions after cyst aspiration. The aspiration was repeated as needed throughout the treatment course to maintain the cyst size and shape. The patient characteristics, radiologic tumor response, and clinical course were reviewed using medical records. The mean follow-up duration was 10.2 (2-28) months. The mean pre-GKRS volume and maximum diameter were 16.7 (5-55.8) mL and 39.0 (31-79) mm, respectively. The mean tumor volume reduction achieved by aspiration was 55.4%. The tumor volume decreased for all lesions, and symptoms were alleviated in all patients. The median overall survival was 10.0 months, and the estimated 1-year survival rate was 41.7% (95% CI: 10.9-70.8%). The local tumor control rate was 100%. No irradiation-related adverse events were observed. f-GKRS for aspirated cystic brain metastasis is a safe, effective, and less invasive management option for large cystic brain metastases.

摘要

肿瘤囊液抽吸后行伽玛刀放射外科手术(GKRS)治疗大型囊性脑转移瘤是一种合理且有效的治疗策略。然而,即使进行抽吸,靶病灶仍倾向于超出立体定向放射外科的理想靶区范围。在这种情况下,局部肿瘤控制率和并发症风险可能是一个关键的挑战。本研究旨在探讨分次 GKRS(f-GKRS)是否能够解决这些问题。2018 年 5 月至 2021 年 4 月,连续 8 例患者的 9 个病灶在囊液抽吸后接受 5 或 10 次 f-GKRS 治疗。在整个治疗过程中,根据需要重复抽吸以维持囊腔的大小和形状。使用病历回顾患者特征、影像学肿瘤反应和临床病程。中位随访时间为 10.2(2-28)个月。GKRS 治疗前的平均肿瘤体积和最大直径分别为 16.7(5-55.8)mL 和 39.0(31-79)mm。抽吸引起的肿瘤体积平均减少 55.4%。所有病灶的肿瘤体积均缩小,所有患者的症状均得到缓解。总的中位生存时间为 10.0 个月,估计 1 年生存率为 41.7%(95%CI:10.9-70.8%)。局部肿瘤控制率为 100%。未观察到与放疗相关的不良事件。对于大型囊性脑转移瘤,f-GKRS 是一种安全、有效且侵袭性较小的治疗选择。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验